This effect was associated with marked induction of p27Kip1 expression and cell cycle arrest in G1 phase in TZ-sensitive cells, thus indicating that once immobilized on the nanoparticle surface, the antibody-derived ligands maintain their specificity for HER2 and block HER2-driven cancer cell proliferation. Here, ERBB2 is linked to cancer.